Vocalbeats.AI Achieves ISO/IEC 42001 Certification, Reinforcing Responsible AI Governance
Callings.ai Launches Outplacement 2.0 at HR Tech 2026, Turning Employee Exits Into Lasting Talent Relationships
VideoGen Unveils Model 1, Its First AI Video Generation Model, and $1 Million in Free AI Credits
Cycode Expands Canadian Presence, Building on Global Momentum in Agentic Development Security
Splashtop Agentic Packr Automates App Packaging for Microsoft Intune
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
San Antonio native Andrea Huizar Beymer will oversee all aspects of operations for the utility….
HIAWATHA, Iowa–(BUSINESS WIRE)–#CrystalGroup—Crystal Group, Inc., a trusted designer and manufacturer of rugged high-performance edge compute…
Revenues excluding Covid test sales increased 16.3% for first fiscal quarter of 2024 vs the…
HANOVER, MD, Oct. 13, 2023 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or…
Demonstrated on-mechanism, single agent anti-tumor activity in heavily pre-treated patients with transcriptionally addicted solid tumors…
Teammates Speak 30+ Languages, Reaching Customers Across Continent NEW BRAUNFELS, Texas, Oct. 13, 2023 (GLOBE…
NEW YORK–(BUSINESS WIRE)–Behavox, the leading provider of AI-driven compliance solutions, today announced that Evercore (NYSE:…
AUGUSTA, Ga.–(BUSINESS WIRE)–#browsersecurity–Conceal, renowned for its innovative approach to browser security, proudly announces a strategic…
DUBLIN–(BUSINESS WIRE)–The “North America Industrial Wearable Devices Market: Industry Trends, Share, Size, Growth, Opportunity and…
NEW YORK–(BUSINESS WIRE)–#biofuture2023–Demy-Colton’s BioFuture™ concluded this week after bringing together hundreds of life sciences, diagnostics,…
Clinical dose escalation data for RMC-6236, a RASMULTI(ON) Inhibitor, show oral bioavailability, well-tolerated safety profile…
The opinion was based on positive results from the pivotal ReSTORE Phase III clinical trial…
Late-breaking amlitelimab Phase 2b data presented at EADV show potential best-in-class profile in atopic dermatitis…
New data from Phase II FENopta study in relapsing multiple sclerosis (RMS) show fenebrutinib crosses…
SAN JOSE, Calif.–(BUSINESS WIRE)–#8021x–Genians, the industry pioneer in NAC-driven Zero Trust Network Access (ZTNA) solutions,…
Data presented during the late-breaker oral presentation of the TREK-AD study demonstrate eblasakimab’s potential as…
Vancouver, British Columbia–(Newsfile Corp. – October 13, 2023) – Fandifi Technology Corp. (CSE: FDM) (FSE:…